Newborns Carry Antibiotic Resistance Genes
Analysis based on 7 articles · First reported Apr 19, 2026 · Last updated Apr 20, 2026
The findings suggest a potential increase in antibiotic resistance, which could lead to higher healthcare costs and a greater need for new antibiotic development. This may negatively impact pharmaceutical companies focused on existing antibiotic lines and create opportunities for those developing novel treatments.
Research presented at ESCMID Global 2026 revealed that antibiotic resistance genes (ARGs) are present in newborns within hours of birth. A study of 105 infants in a neonatal intensive care unit, led by Professor Elias Iosifidis at Aristotle University of Thessaloniki and lead author Dr. Argyro Ftergioti, analyzed meconium samples. The study found a median of eight ARGs per sample, with oqxA (98%) and qnrS (96%) being the most common. Genes linked to Carbapenem resistance were detected in 21% of samples. The presence of ARGs was associated with maternal hospitalization during pregnancy and central venous catheter placement in newborns, suggesting both maternal transmission and early hospital exposure contribute to their establishment. This highlights the importance of surveillance and infection control in neonatal care.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard